Julia Strandberg

Insider Reports History

Entity
Individual
Location
C/O Pear Therapeutics, Inc., 200 State Street, 13 Th Floor, Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julia Strandberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 1.41M Feb 15, 2023 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 78.8K Feb 16, 2022 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Common Stock 41.3K Jan 14, 2023 Direct
Pear Therapeutics, Inc. Chief Commercial Officer Class A Common Stock 28.6K Jan 20, 2023 Direct

Insider Reports Filed by Julia Strandberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEARQ Pear Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Commercial Officer
PEARQ Pear Therapeutics, Inc. Jan 20, 2023 1 -$14.3K 4 Jan 24, 2023 Chief Commercial Officer
PEARQ Pear Therapeutics, Inc. Jan 14, 2023 2 $0 4 Jan 18, 2023 Chief Commercial Officer
PEARQ Pear Therapeutics, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 Chief Commercial Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 3 $0 4 Dec 7, 2021 Chief Commercial Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Chief Commercial Officer